Chinese buyers struggle through Cfius quagmire

Donald Trump's delay in appointing key officials is already slowing down the approval process for M&A deals in the US – even before any policy changes kick in.
June 13, 2017

Excitement and suprise greeted a decision by a key US regulatory panel to approve ChemChina's record $43 billion acquisition of Syngenta last August.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media